Association between Paraoxonase-1 p.Q192R Polymorphism and Coronary Artery Disease susceptibility in the Colombian Population

David Corredor-Orlandelli,1,* Santiago Sambracos-Parrado,1,* Santiago Mantilla-García,1 Josué Tovar-Tirado,1 Valentina Vega-Ramírez,1 Santiago David Mendoza-Ayús,1 Laura Catalina Peña,1 María Fernanda Leal,1 Juliana Rodrígu...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Corredor-Orlandelli D, Sambracos-Parrado S, Mantilla-García S, Tovar-Tirado J, Vega-Ramírez V, Mendoza-Ayús SD, Peña LC, Leal MF, Rodríguez-Carrillo J, León-Torres J, Pardo-Oviedo JM, Parra Abaunza K, Contreras Bravo NC, Ortega-Recalde O, Fonseca Mendoza DJ
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2021
Materias:
Acceso en línea:https://doaj.org/article/3f9ccc792cd240abbea37565e2a9f546
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:3f9ccc792cd240abbea37565e2a9f546
record_format dspace
spelling oai:doaj.org-article:3f9ccc792cd240abbea37565e2a9f5462021-11-04T19:00:26ZAssociation between Paraoxonase-1 p.Q192R Polymorphism and Coronary Artery Disease susceptibility in the Colombian Population1178-2048https://doaj.org/article/3f9ccc792cd240abbea37565e2a9f5462021-11-01T00:00:00Zhttps://www.dovepress.com/association-between-paraoxonase-1-pq192r-polymorphism-and-coronary-art-peer-reviewed-fulltext-article-VHRMhttps://doaj.org/toc/1178-2048David Corredor-Orlandelli,1,* Santiago Sambracos-Parrado,1,* Santiago Mantilla-García,1 Josué Tovar-Tirado,1 Valentina Vega-Ramírez,1 Santiago David Mendoza-Ayús,1 Laura Catalina Peña,1 María Fernanda Leal,1 Juliana Rodríguez-Carrillo,1 Juanita León-Torres,1 Juan Mauricio Pardo-Oviedo,2 Katherine Parra Abaunza,3 Nora Contreras Contreras Bravo,1 Oscar Ortega-Recalde,1 Dora Janeth Fonseca Mendoza1 1Center for Research in Genetics and Genomics – CIGGUR, GENIUROS Research Group, School of Medicine and Health Sciences, Universidad Del Rosario, Bogotá, Colombia; 2School of Medicine and Health Sciences, Universidad del Rosario, Bogotá, Colombia; 3Hospital Universitario Mayor – Méderi, Universidad del Rosario, Bogotá, Colombia*These authors contributed equally to this workCorrespondence: Dora Janeth Fonseca MendozaCenter for Research in Genetics and Genomics (CIGGUR), GENIUROS Research Group, School of Medicine and Health Sciences, Universidad del Rosario, Cra 24 # 63C69, Bogotá, 112111, ColombiaTel/Fax +57 12920200Email dora.fonseca@urosario.edu.coBackground: Paraoxonase-1 (PON1), a glycoprotein associated with serum high-density lipoprotein (HDL), has a central role in metabolizing lipid peroxides, exhibiting antiatherogenic properties. The polymorphism p.Q192R has been previously associated with coronary artery disease (CAD) susceptibility and clopidogrel response.Purpose: We aimed at investigating the association of PON1 p.Q192R with CAD and clopidogrel response in Colombian population.Patients and Methods: The study was conducted among 163 patients diagnosed with CAD and treated with clopidogrel. The allele frequencies for the PON1 192Q and 192R alleles were determined in cases and Latin-American controls obtained from the public database gnomAD (n = 17,711). Response to clopidogrel was determined by assessing the platelet function using the INNOVANCE PFA-200 System. We determined the association between PON1 p.Q192R polymorphism, increased susceptibility to CAD and high on-treatment platelet reactivity (HPR) by using odds ratio (OR) and 95% confidence interval (CI) on four genetic models.Results: The allele frequencies for the PON1 192Q and 192R alleles were 0.60 and 0.40, respectively. The allele distribution was found to be statistically different from the control group and other ethnic groups. The allele 192R was positively associated with decreased susceptibility to CAD under a dominant model (OR, 0.58; 95% CI, 0.42– 0.8; P < 0.01). We found no association between the polymorphism and HPR.Conclusion: We propose that PON1 p.Q192R is a potentially useful marker for CAD susceptibility in the Colombian population and lacks association with HPR under clopidogrel treatment.Keywords: PON1, genetic risk, cardiovascular disease susceptibility, platelet reactivity, clopidogrelCorredor-Orlandelli DSambracos-Parrado SMantilla-García STovar-Tirado JVega-Ramírez VMendoza-Ayús SDPeña LCLeal MFRodríguez-Carrillo JLeón-Torres JPardo-Oviedo JMParra Abaunza KContreras Bravo NCOrtega-Recalde OFonseca Mendoza DJDove Medical Pressarticlepon1genetic riskcardiovascular disease susceptibilityplatelet reactivityclopidogrelDiseases of the circulatory (Cardiovascular) systemRC666-701ENVascular Health and Risk Management, Vol Volume 17, Pp 689-699 (2021)
institution DOAJ
collection DOAJ
language EN
topic pon1
genetic risk
cardiovascular disease susceptibility
platelet reactivity
clopidogrel
Diseases of the circulatory (Cardiovascular) system
RC666-701
spellingShingle pon1
genetic risk
cardiovascular disease susceptibility
platelet reactivity
clopidogrel
Diseases of the circulatory (Cardiovascular) system
RC666-701
Corredor-Orlandelli D
Sambracos-Parrado S
Mantilla-García S
Tovar-Tirado J
Vega-Ramírez V
Mendoza-Ayús SD
Peña LC
Leal MF
Rodríguez-Carrillo J
León-Torres J
Pardo-Oviedo JM
Parra Abaunza K
Contreras Bravo NC
Ortega-Recalde O
Fonseca Mendoza DJ
Association between Paraoxonase-1 p.Q192R Polymorphism and Coronary Artery Disease susceptibility in the Colombian Population
description David Corredor-Orlandelli,1,* Santiago Sambracos-Parrado,1,* Santiago Mantilla-García,1 Josué Tovar-Tirado,1 Valentina Vega-Ramírez,1 Santiago David Mendoza-Ayús,1 Laura Catalina Peña,1 María Fernanda Leal,1 Juliana Rodríguez-Carrillo,1 Juanita León-Torres,1 Juan Mauricio Pardo-Oviedo,2 Katherine Parra Abaunza,3 Nora Contreras Contreras Bravo,1 Oscar Ortega-Recalde,1 Dora Janeth Fonseca Mendoza1 1Center for Research in Genetics and Genomics – CIGGUR, GENIUROS Research Group, School of Medicine and Health Sciences, Universidad Del Rosario, Bogotá, Colombia; 2School of Medicine and Health Sciences, Universidad del Rosario, Bogotá, Colombia; 3Hospital Universitario Mayor – Méderi, Universidad del Rosario, Bogotá, Colombia*These authors contributed equally to this workCorrespondence: Dora Janeth Fonseca MendozaCenter for Research in Genetics and Genomics (CIGGUR), GENIUROS Research Group, School of Medicine and Health Sciences, Universidad del Rosario, Cra 24 # 63C69, Bogotá, 112111, ColombiaTel/Fax +57 12920200Email dora.fonseca@urosario.edu.coBackground: Paraoxonase-1 (PON1), a glycoprotein associated with serum high-density lipoprotein (HDL), has a central role in metabolizing lipid peroxides, exhibiting antiatherogenic properties. The polymorphism p.Q192R has been previously associated with coronary artery disease (CAD) susceptibility and clopidogrel response.Purpose: We aimed at investigating the association of PON1 p.Q192R with CAD and clopidogrel response in Colombian population.Patients and Methods: The study was conducted among 163 patients diagnosed with CAD and treated with clopidogrel. The allele frequencies for the PON1 192Q and 192R alleles were determined in cases and Latin-American controls obtained from the public database gnomAD (n = 17,711). Response to clopidogrel was determined by assessing the platelet function using the INNOVANCE PFA-200 System. We determined the association between PON1 p.Q192R polymorphism, increased susceptibility to CAD and high on-treatment platelet reactivity (HPR) by using odds ratio (OR) and 95% confidence interval (CI) on four genetic models.Results: The allele frequencies for the PON1 192Q and 192R alleles were 0.60 and 0.40, respectively. The allele distribution was found to be statistically different from the control group and other ethnic groups. The allele 192R was positively associated with decreased susceptibility to CAD under a dominant model (OR, 0.58; 95% CI, 0.42– 0.8; P < 0.01). We found no association between the polymorphism and HPR.Conclusion: We propose that PON1 p.Q192R is a potentially useful marker for CAD susceptibility in the Colombian population and lacks association with HPR under clopidogrel treatment.Keywords: PON1, genetic risk, cardiovascular disease susceptibility, platelet reactivity, clopidogrel
format article
author Corredor-Orlandelli D
Sambracos-Parrado S
Mantilla-García S
Tovar-Tirado J
Vega-Ramírez V
Mendoza-Ayús SD
Peña LC
Leal MF
Rodríguez-Carrillo J
León-Torres J
Pardo-Oviedo JM
Parra Abaunza K
Contreras Bravo NC
Ortega-Recalde O
Fonseca Mendoza DJ
author_facet Corredor-Orlandelli D
Sambracos-Parrado S
Mantilla-García S
Tovar-Tirado J
Vega-Ramírez V
Mendoza-Ayús SD
Peña LC
Leal MF
Rodríguez-Carrillo J
León-Torres J
Pardo-Oviedo JM
Parra Abaunza K
Contreras Bravo NC
Ortega-Recalde O
Fonseca Mendoza DJ
author_sort Corredor-Orlandelli D
title Association between Paraoxonase-1 p.Q192R Polymorphism and Coronary Artery Disease susceptibility in the Colombian Population
title_short Association between Paraoxonase-1 p.Q192R Polymorphism and Coronary Artery Disease susceptibility in the Colombian Population
title_full Association between Paraoxonase-1 p.Q192R Polymorphism and Coronary Artery Disease susceptibility in the Colombian Population
title_fullStr Association between Paraoxonase-1 p.Q192R Polymorphism and Coronary Artery Disease susceptibility in the Colombian Population
title_full_unstemmed Association between Paraoxonase-1 p.Q192R Polymorphism and Coronary Artery Disease susceptibility in the Colombian Population
title_sort association between paraoxonase-1 p.q192r polymorphism and coronary artery disease susceptibility in the colombian population
publisher Dove Medical Press
publishDate 2021
url https://doaj.org/article/3f9ccc792cd240abbea37565e2a9f546
work_keys_str_mv AT corredororlandellid associationbetweenparaoxonase1pq192rpolymorphismandcoronaryarterydiseasesusceptibilityinthecolombianpopulation
AT sambracosparrados associationbetweenparaoxonase1pq192rpolymorphismandcoronaryarterydiseasesusceptibilityinthecolombianpopulation
AT mantillagarcias associationbetweenparaoxonase1pq192rpolymorphismandcoronaryarterydiseasesusceptibilityinthecolombianpopulation
AT tovartiradoj associationbetweenparaoxonase1pq192rpolymorphismandcoronaryarterydiseasesusceptibilityinthecolombianpopulation
AT vegaramirezv associationbetweenparaoxonase1pq192rpolymorphismandcoronaryarterydiseasesusceptibilityinthecolombianpopulation
AT mendozaayussd associationbetweenparaoxonase1pq192rpolymorphismandcoronaryarterydiseasesusceptibilityinthecolombianpopulation
AT penalc associationbetweenparaoxonase1pq192rpolymorphismandcoronaryarterydiseasesusceptibilityinthecolombianpopulation
AT lealmf associationbetweenparaoxonase1pq192rpolymorphismandcoronaryarterydiseasesusceptibilityinthecolombianpopulation
AT rodriguezcarrilloj associationbetweenparaoxonase1pq192rpolymorphismandcoronaryarterydiseasesusceptibilityinthecolombianpopulation
AT leontorresj associationbetweenparaoxonase1pq192rpolymorphismandcoronaryarterydiseasesusceptibilityinthecolombianpopulation
AT pardooviedojm associationbetweenparaoxonase1pq192rpolymorphismandcoronaryarterydiseasesusceptibilityinthecolombianpopulation
AT parraabaunzak associationbetweenparaoxonase1pq192rpolymorphismandcoronaryarterydiseasesusceptibilityinthecolombianpopulation
AT contrerasbravonc associationbetweenparaoxonase1pq192rpolymorphismandcoronaryarterydiseasesusceptibilityinthecolombianpopulation
AT ortegarecaldeo associationbetweenparaoxonase1pq192rpolymorphismandcoronaryarterydiseasesusceptibilityinthecolombianpopulation
AT fonsecamendozadj associationbetweenparaoxonase1pq192rpolymorphismandcoronaryarterydiseasesusceptibilityinthecolombianpopulation
_version_ 1718444644147134464